Search results
Results from the WOW.Com Content Network
Syrup of ipecac (/ ˈ ɪ p ɪ k æ k /), or simply ipecac, is a drug that was once widely used as an expectorant (in low doses) and a rapid-acting emetic (in higher doses). It is obtained from the dried rhizome and roots of the ipecacuanha plant ( Carapichea ipecacuanha ), from which it derives its name.
The condition causes nausea, vomiting, fullness after eating, early satiety (feeling full before the meal is finished), abdominal pain, and bloating. Domperidone can be used to increase the transit of food through the stomach by increasing gastrointestinal peristalsis and hence to treat gastroparesis.
Weight loss drugs have been developed since the early twentieth century, and many have been banned or withdrawn from the market due to adverse effects, including deaths; other drugs proved ineffective. Although many earlier drugs were stimulants such as amphetamines, in the early 2020s, GLP-1 receptor agonists became popular for weight loss.
Ozempic, a once-weekly injection used for the treatment of type 2 diabetes, has skyrocketed in use after people were reportedly prescribed the FDA-approved diabetes medication as an “off-label ...
Researchers found that several popular weight-loss drugs could cause rare but serious complications. Weight-loss drugs linked to stomach paralysis, study finds Skip to main content
The chronic form typically presents more gradually with abdominal pain after eating, unintentional weight loss, vomiting, and fear of eating. [ 1 ] [ 2 ] Risk factors for acute intestinal ischemia include atrial fibrillation , heart failure , chronic kidney failure , being prone to forming blood clots , and previous myocardial infarction . [ 2 ]
Osmotic diarrhea, distension of the small bowel leading to crampy abdominal pain, and reduced blood volume can result. Late dumping syndrome occurs 2 to 3 hours after a meal. It results from excessive movement of sugar into the intestine, which raises the body's blood glucose level and causes the pancreas to increase its release of the hormone ...
On Oct. 5, 2023, researchers reported people taking GLP-1 agonists — the class of drugs that includes Ozempic and its sister drug Wegovy, which is approved for weight loss — may be at an ...